Specialty Pharmaceuticals in Development - Nexus 2019

ACPE UAN #:  0233-0000-19-058-H04-P

Release DateOctober 30, 2019

Expiration Date:   October 30, 2022

Activity Type:    Knowledge-based

Contact Hours:  1.25 

Activity Fee:  Member:  FREE        Non-Member: $30

Target Audience: Pharmacists who practice in managed care settings.

Activity Description

Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs. It is anticipated that this trend will continue. How will these specialty medications affect the dynamic health care landscape and managed care pharmacy? This Pipeline Session will focus on new and emerging specialty medications and explore their likely role in therapy. This session will also discuss the potential impact of these agents on the managed care market. 

Learning Objectives:

At the completion of this activity, participants should be able to: 

  1. Recognize recently approved specialty medications.
  2. Identify specialty medications that are likely to be approved in the next 12 months.
  3. Discuss the mechanism of action, indications, efficacy, and safety of new and emerging specialty medications.
  4. Report the likely effect of new specialty medications on the managed care market.   

Schedule of Educational Activity

This activity consists of an audio recording, pre-test assessment questions (not required to pass to continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation.

Accreditation Statement:

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities.  AMCP intends that all CPE activities be independent, objective, balanced, evidence-based, and free of any commercial bias.

CPE Requirements:   

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP Nexus 2019.

CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.


Brian Sweet | BSPharm, MBA | Executive Director, Real World Evidence, Oncology | Bristol-Myers Squibb | Grand Island, New York.

System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites.  View the minimum technical and system requirements for continuing education online learning activities.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-0000-19-058-H04-P 1.25 Contact Hours October 30, 2019 - October 30, 2022